Cardlytics (CDLX) Equity Ratio (2017 - 2026)

Cardlytics has reported Equity Ratio for 10 years, with the latest figure at 0.02 in Q1 2026.

• For the quarter ending Q1 2026, Equity Ratio fell 108.73% year-over-year to 0.02; the trailing twelve-month figure through Mar 2026 stood at 0.02 (down 108.73% YoY), and the FY2025 full-year result was 0.02, down 112.78% from the prior year.
• Equity Ratio for Q1 2026 stood at 0.02, up from 0.02 in the prior quarter.
• The five-year high for Equity Ratio was 0.58 in Q1 2022, with the low at 0.02 in Q4 2025.
• Historically, Equity Ratio has averaged 0.27 across 5 years, with a median of 0.31 in 2022.
• Annual changes were most pronounced in 2024 — Equity Ratio grew 5.43% — and 2025, when it tumbled 112.78%.
• Cardlytics' Equity Ratio stood at 0.31 in 2022, then fell by 23.31% to 0.23 in 2023, then retreated by 24.09% to 0.18 in 2024, then tumbled by 112.78% to 0.02 in 2025, then surged by 33.43% to 0.02 in 2026.
• The last three Equity Ratio figures came in at 0.02 (Q1 2026), 0.02 (Q4 2025), and 0.02 (Q3 2025), per Business Quant data.